MassChallenge Startups Create Impact

2,928

Startups Accelerated

$8.6B

Funding Raised

$3.6B

Revenue Generated

186K+

Jobs Created

Our startups

Be inspired. Search our startups.

Clear  
Octarine
Octarine

Cannabinoids and psychedelics are poised to become breakthrough therapies for a range of debilitating conditions. However, issues with the cost-effective and scalable production of these API's, as well as pharmacokinetic issues such as low solubility, bioavailability and stability limit their application. Octarine produces these complex molecules at scale with yeast fermentation, and further, uses proprietary enzymatic modification technology to produce novel derivatives with improved properties
Octarine harnesses synthetic biology to develop improved cannabinoid and psychedelic therapeutics to improve human health and well-being

Connect with Octarine

2020

2020 Finalist Switzerland

Sub industry

Therapeutics (Pharma / Biotech)

Additional Industries
Food
Beverages & Restaurants

Mission

Our mission is to equip bold entrepreneurs to disrupt the status quo and to create meaningful change.